Nursing care
Acyclovir: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Acyclovir nursing care depends on early administration and renal protection. For shingles, it works best when started within 72 hours of rash onset; the patient must stay well hydrated to protect the kidneys, and the IV form is infused slowly over about an hour, never as a rapid push.
Mechanism, simply
Acyclovir is a nucleoside analogue that gets converted to its active form only inside virus-infected cells, by an enzyme the herpes viruses themselves produce. Once activated, it is incorporated into viral DNA and stops the chain from being built further, halting viral replication.
Because activation depends on a viral enzyme, uninfected cells convert very little of the drug, which is why acyclovir has a relatively wide margin between antiviral effect and toxicity in most patients. It does not eradicate latent virus sitting in nerve ganglia, so it shortens and lessens outbreaks rather than curing the underlying infection.
Indications you will see on the ward
The most common indications are herpes simplex infections, genital and oral, and herpes zoster, shingles. For shingles, the timing detail matters clinically and on the exam: acyclovir should be started within 72 hours of the rash appearing, because delayed treatment does little to reduce the duration of the outbreak or the risk of post-herpetic neuralgia.
It is also used for varicella in patients at higher risk of complications, and IV acyclovir is the treatment for herpes encephalitis, a situation where delay carries serious neurological consequences. Immunocompromised patients, including those on chemotherapy or post-transplant, often receive prophylactic acyclovir to prevent reactivation of latent herpes viruses.
Assessment before administration
Check baseline renal function before starting, and reassess it during therapy, particularly with the IV form, since acyclovir can crystallise in the renal tubules if the patient is dehydrated. Confirm the patient is well hydrated before the infusion begins and encourage oral fluids throughout treatment to protect kidney function.
Assess the site and extent of the lesions to establish a baseline for evaluating response, and note the exact time of rash or symptom onset, since that timestamp determines whether the 72-hour window for shingles treatment has already passed. Review current renal-affecting medications and confirm IV access is patent, since extravasation of acyclovir is irritating to tissue.
Toxicity and the antidote
The main toxicity is nephrotoxicity from crystal deposition in the renal tubules, presenting as rising creatinine, reduced urine output, or flank discomfort, and it is largely preventable with adequate hydration before and during infusion. Rapid IV administration increases this risk sharply, which is why the infusion is given slowly, typically over about an hour, rather than as a bolus.
There is no specific pharmacological antidote to acyclovir toxicity. Management is supportive: stop or slow the infusion, ensure aggressive hydration, and in significant renal impairment, haemodialysis can remove the drug effectively since acyclovir is not highly protein bound. Neurotoxicity, with confusion, tremor, or lethargy, can occur in patients with pre-existing renal impairment who have not had their dose adjusted.
Interactions that matter
Probenecid reduces renal clearance of acyclovir and can raise blood levels, increasing toxicity risk. Other nephrotoxic drugs, including aminoglycosides and certain contrast agents, compound the kidney risk when given alongside acyclovir, so cumulative renal burden should be considered in any patient on multiple such agents.
Zidovudine combined with acyclovir has been associated with increased drowsiness and lethargy in some patients, and caution is warranted with any other drug that itself requires dose adjustment for renal function, since acyclovir can transiently reduce clearance capacity. Always check a current medication list against renal function before adding acyclovir.
What the patient must be told
Tell the patient to start treatment as soon as possible after the rash appears, since the window for meaningful benefit in shingles closes at 72 hours. Waiting to see if it gets better on its own before calling the clinic is the single most common reason acyclovir underperforms.
Instruct the patient to drink fluids generously throughout the course, particularly if taking the oral form at home without direct supervision, since dehydration is the main driver of the kidney risk. For genital or oral herpes, advise the patient that the drug reduces symptoms and shedding but does not cure the infection, and that transmission precautions still apply during active outbreaks.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Why does timing matter so much for acyclovir in shingles?
The virus is actively replicating early in the outbreak, and acyclovir only acts on that replication. Starting within 72 hours of the rash appearing meaningfully shortens the outbreak and reduces the risk of post-herpetic neuralgia; starting later has much less benefit.
How fast should IV acyclovir be infused?
It is infused slowly, generally over about an hour, never as a rapid bolus. Fast infusion sharply increases the risk of crystal formation in the renal tubules and acute kidney injury.
What is the antidote for acyclovir toxicity?
There is no specific antidote. Management is supportive, focused on hydration and slowing or stopping the infusion; in significant renal impairment, haemodialysis can remove the drug since it is not highly protein bound.
Does acyclovir cure herpes infections?
No. It suppresses active viral replication and shortens outbreaks, but the virus remains latent in nerve tissue afterward. Patients need this explained clearly to set realistic expectations about recurrence.
What should be monitored during IV acyclovir therapy?
Renal function, particularly serum creatinine and urine output, along with hydration status and IV site integrity. Baseline renal function should be checked before starting and reassessed during the course, especially in older adults or those with pre-existing renal impairment.
More on pharmacology
Guides on this